Today's RNS's28 Mar 2024 07:35
Hi All - I am at the lower end of the scale with regards my investment & have been in this situation with a Biotech Company before.As a shareholder, like many others, one feels we have been shafted however provided we have positive results in Qtr 2 2024 it should be a different story.I do agree with an earlier post that there will likely need to be a further fund raise but hopefully at a much higher SP.
The alternatives to Sareum's fund raise is that the Company would have gone under so we now all have a chance of recovering our costs & maybe more.
Clearly the BOD made an unwise decision with their earlier method of fund raising & was also a sign of desperation.
Clearly we will see a drop this morning in the SP & now need to wait to Qtr 2 2024 for clinical results.
PS If I had the funds I would likely Buy the shares on offer at 10p in order to average down.